{"id":"NCT00409188","sponsor":"EMD Serono","briefTitle":"Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)","officialTitle":"A Multi-center Phase III Randomized, Double-blind Placebo-controlled Study of the Cancer Vaccine StimuvaxÂ® (L-BLP25 or BLP25 Liposome Vaccine) in Non-small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-01","primaryCompletion":"2012-04","completion":"2015-04","firstPosted":"2006-12-08","resultsPosted":"2015-11-20","lastUpdate":"2015-11-20"},"enrollment":1513,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Non-small Cell Lung Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"Tecemotide (L-BLP25)","otherNames":[]},{"type":"DRUG","name":"Single low dose cyclophosphamide","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Tecemotide (L-BLP25)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether the cancer vaccine tecemotide (L-BLP25) in addition to best supportive care is effective in prolonging the lives of subjects with unresectable stage III non-small cell lung cancer, compared to best supportive care alone.\n\nA local ancillary (sub) study in European centers will evaluate the immune response in peripheral blood after tecemotide (L-BLP25) or placebo vaccination.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"Up to 66 months","effectByArm":[{"arm":"Tecemotide (L-BLP25) + Cyclophosphamide","deltaMin":25.6,"sd":null},{"arm":"Saline + Placebo","deltaMin":22.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1566"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":18},"locations":{"siteCount":290,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","China","Czechia","Denmark","France","Germany","Greece","Hong Kong","Hungary","India","Ireland","Israel","Italy","Mexico","Netherlands","Poland","Portugal","Romania","Russia","Singapore","Slovakia","South Korea","Spain","Sweden","Switzerland","Taiwan","United Kingdom"]},"refs":{"pmids":["24331154","24976972","34870327","25722382"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":303,"n":1024},"commonTop":["Cough","Dyspnoea","Fatigue","Back pain","Nausea"]}}